Danazol 200 MG Oral Capsule — RxCUI 197555
RxNorm drug concept · Semantic clinical drug
RxCUI 197555
Semantic clinical drug · SCD
● Current RxNorm concept 11 FDA products
23 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197555
Official nameDanazol 200 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped11
Package NDCs mapped23
Reported Medicaid activity (SDUD)190 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Danazol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That depends on why it was prescribed for you. For endometriosis, danazol suppresses the hormonal signals that cause abnormal tissue to grow outside your uterus — over several mont...
- What exactly is danazol treating in my body?
- Taking danazol with a meal — especially one that contains some fat — significantly increases how much of the drug your body absorbs. Studies show absorption can be 3 to 4 times hig...
- Should I take my danazol capsule with food or on an empty stomach?
🕸️ Concept Web — How Danazol 200 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Danazol 200 MG Oral Capsule
RxCUI 197555 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Danazol
3102IN
-
Danazol
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Danazol Oral Capsule
371681SCDF -
Danazol Oral Product
1151842SCDG -
Danazol Pill
1151843SCDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Danazol Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Danazol 200 MG
317628SCDC
-
Danazol 200 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Danazol 200 MG
SCDC · 317628 -
Danazol Oral Capsule
SCDF · 371681 -
Danazol Oral Product
SCDG · 1151842 -
Danazol Pill
SCDG · 1151843
📦 FDA Products & Package NDCs
11 products · 23 package NDCs
23 package NDCs map to RxCUI 197555 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00527-1368-01 | 100 CAPSULE in 1 BOTTLE (0527-1368-01) | Danazol | Lannett Company, Inc. | 2007-04-19 |
| 00527-1369-01 | 100 CAPSULE in 1 BOTTLE (0527-1369-01) | Danazol | Lannett Company, Inc. | 2005-09-28 |
| 00527-1369-06 | 60 CAPSULE in 1 BOTTLE (0527-1369-06) | Danazol | Lannett Company, Inc. | 2005-09-28 |
| 00527-1392-01 | 100 CAPSULE in 1 BOTTLE (0527-1392-01) | Danazol | Lannett Company, Inc. | 2007-04-19 |
| 00555-0633-02 | 100 CAPSULE in 1 BOTTLE (0555-0633-02) | Danazol | Teva Pharmaceuticals USA, Inc. | 1998-06-25 |
| 00555-0634-02 | 100 CAPSULE in 1 BOTTLE (0555-0634-02) | Danazol | Teva Pharmaceuticals USA, Inc. | 1998-06-25 |
| 00555-0635-02 | 100 CAPSULE in 1 BOTTLE (0555-0635-02) | Danazol | Teva Pharmaceuticals USA, Inc. | 1996-08-09 |
| 00555-0635-09 | 60 CAPSULE in 1 BOTTLE (0555-0635-09) | Danazol | Teva Pharmaceuticals USA, Inc. | 1996-08-09 |
| 62135-0475-60 | 60 CAPSULE in 1 BOTTLE (62135-475-60) | Danazol | Chartwell RX, LLC. | 2023-02-27 |
| 62135-0476-60 | 60 CAPSULE in 1 BOTTLE (62135-476-60) | Danazol | Chartwell RX, LLC. | 2023-02-27 |
| 62135-0477-60 | 60 CAPSULE in 1 BOTTLE (62135-477-60) | Danazol | Chartwell RX, LLC. | 2023-02-27 |
| 71205-0861-00 | 100 CAPSULE in 1 BOTTLE (71205-861-00) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0861-30 | 30 CAPSULE in 1 BOTTLE (71205-861-30) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0861-55 | 500 CAPSULE in 1 BOTTLE (71205-861-55) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0861-60 | 60 CAPSULE in 1 BOTTLE (71205-861-60) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0861-72 | 120 CAPSULE in 1 BOTTLE (71205-861-72) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0861-90 | 90 CAPSULE in 1 BOTTLE (71205-861-90) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0862-00 | 100 CAPSULE in 1 BOTTLE (71205-862-00) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0862-30 | 30 CAPSULE in 1 BOTTLE (71205-862-30) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0862-55 | 500 CAPSULE in 1 BOTTLE (71205-862-55) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0862-60 | 60 CAPSULE in 1 BOTTLE (71205-862-60) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0862-72 | 120 CAPSULE in 1 BOTTLE (71205-862-72) | Danazol | Proficient Rx LP | 2022-04-01 |
| 71205-0862-90 | 90 CAPSULE in 1 BOTTLE (71205-862-90) | Danazol | Proficient Rx LP | 2022-04-01 |
Observed labelers:
Proficient Rx LP (12) ·
Lannett Company, Inc. (4) ·
Teva Pharmaceuticals USA, Inc. (4) ·
Chartwell RX, LLC. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.